DFX Intelligence
The names on this page are hidden. Create a free account to reveal 5 records a month, or get Private Credit Intelligence at $249 a month for every name. Every figure, date and source on this page is public either way.
Borrower
A•• T••••••••• S•
Biotechnologygroup grade Aon a schedule nowsponsor unattributed
Principal held
at least $17.0M
sum of BDC pieces, a lower bound
Fair value
$16.9M
102c on cost, debt pieces
Unfunded
n/a
commitments not yet drawn
BDC lenders
2
2 on the latest quarter
Facilities
2
3 equity pieces beside them
Next maturity
Aug 15, 2029
no dated debt inside 24 months
On the tape since
Sep 30, 2022
latest Jun 30, 2026
Events
2
dated, non-routine
Capital structure as the BDCs see it
latest quarter end Jun 30, 2026
| Facility | Held | On cost | Pricing | Maturity | BDCs |
|---|---|---|---|---|---|
| first lien term loan first lien | at least $17.0M | 102c | S+750 bp | Aug 15, 2029 | 2 |
| first lien delayed draw term loan first lien exited Dec 31, 2022 | at least $0 | n/a | S+750 bp | unstated | 1 |
Lenders
every BDC piece at the latest quarter end
| BDC | Instrument | Principal | Fair value | Rate |
|---|---|---|---|---|
| O•••••• S•••••••• L•••••• C••• | equity equity C••••• S•••• | n/a | $0 | |
| O•••••• S•••••••• L•••••• C••• | term loan first lien F•••• L••• T••• L••• | $6.6M | $6.6M 102c | S+750 bp |
| O•••••• S•••••••• L•••••• C••• | warrants equity W••••••• | n/a | $1,000 1c | |
| O•••••• S•••••••• C••••• F••• | term loan first lien F•••• L••• T••• L••• | $10.4M | $10.4M 102c | S+750 bp |
| O•••••• S•••••••• C••••• F••• | warrants equity W••••••• | n/a | $1,000 0c |
Through time
the borrower's pieces summed across BDCs, every quarter end
| Quarter end | BDCs | Principal held | Fair value | On cost | PIK pieces |
|---|---|---|---|---|---|
| Jun 30, 2026 | 2 | $17.0M | $16.9M | 102c | 0 |
| Mar 31, 2026 | 2 | $17.0M | $16.9M | 102c | 0 |
| Dec 31, 2025 | 2 | $17.0M | $16.8M | 101c | 0 |
| Sep 30, 2025 | 2 | $17.0M | $16.7M | 101c | 0 |
| Jun 30, 2025 | 2 | $17.0M | $16.7M | 102c | 0 |
| Mar 31, 2025 | 2 | $17.0M | $16.6M | 101c | 0 |
| Dec 31, 2024 | 2 | $17.0M | $16.6M | 101c | 0 |
| Sep 30, 2024 | 2 | $17.0M | $16.6M | 101c | 0 |
| Jun 30, 2024 | 2 | $17.0M | $16.6M | 101c | 0 |
| Mar 31, 2024 | 2 | $17.0M | $16.5M | 101c | 0 |
| Dec 31, 2023 | 2 | $17.0M | $16.1M | 99c | 0 |
| Sep 30, 2023 | 2 | $17.0M | $16.1M | 100c | 0 |
| Jun 30, 2023 | 2 | $17.0M | $16.1M | 100c | 0 |
| Mar 31, 2023 | 2 | $17.0M | $16.1M | 100c | 0 |
| Dec 31, 2022 | 1 | $6.6M | $6.2M | 100c | 0 |
| Sep 30, 2022 | 2 | $23.6M | $22.3M | 100c | 0 |
What changed
- Facility left every BDC scheduleDec 31, 2022
- New borrower on a BDC scheduleSep 30, 2022
Sponsor
No sponsor attribution: no portfolio page, deal announcement or Form D signer consensus names an owner for this borrower group.
Identity
- Group key
- A•• T•••••••••derivedthe codename stem after legal suffixes and deal words
- Spellings
- 1 across 2 BDCsderived
- Industry
- Biotechnologyreportedas one filer wrote it